Cargando…

Management of Patients with Type V Hyperlipoproteinemia: An Uncommon Phenotype of Dyslipidemia with Chylomicronemia and Severe Hypertriglyceridemia

Hypertriglyceridemia (HTG) remains a risk-enhancing factor of atherosclerotic cardiovascular disease. We aimed to report real-world data on the management of patients with type V hyperlipoproteinemia (HLP5), an uncommon phenotype of dyslipidemia characterized by fasting chylomicronemia and severe HT...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chang, Ya-Hui, Lin, Dai-Yi, Tsai, Chia-Ling, Liang, Chih-Hung, Yu, Yu-Ting, Hsieh, Yi-Lin, Chuang, Jen-Yu, Chen, Yi-Han, Yeh, Hung-I, Lin, Chao-Feng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9866642/ https://www.ncbi.nlm.nih.gov/pubmed/36675730 http://dx.doi.org/10.3390/jpm13010068

Ejemplares similares

A polygenic basis for four classical Fredrickson hyperlipoproteinemia phenotypes that are characterized by hypertriglyceridemia
por: Hegele, Robert A., et al.
Publicado: (2009)

Hypertriglyceridemia Induced Pancreatitis (Chylomicronemia Syndrome) Treated with Supportive Care
por: Uysal, Emin, et al.
Publicado: (2014)

Differentiating Familial Chylomicronemia Syndrome From Multifactorial Severe Hypertriglyceridemia by Clinical Profiles
por: O’Dea, Louis St L, et al.
Publicado: (2019)

Causes, clinical findings and therapeutic options in chylomicronemia syndrome, a special form of hypertriglyceridemia
por: Paragh, György, et al.
Publicado: (2022)

Case of familial hyperlipoproteinemia type III hypertriglyceridemia induced acute pancreatitis: Role for outpatient apheresis maintenance therapy
por: Saleh, Mohannad Abou, et al.
Publicado: (2017)

Therapeutic management of hyperlipoproteinemia (a)
por: Kosmas, Constantine E, et al.
Publicado: (2019)

Recurrent Hypertriglyceridemia-Induced Pancreatitis due to Multifactorial Chylomicronemia Syndrome in a Patient With Ketosis-Prone Diabetes Mellitus
por: Yotsapon, Thewjitcharoen, et al.
Publicado: (2022)

Aggravation of Hypertriglyceridemia and Acute Pancreatitis in a Bipolar Patient Treated with Quetiapine
por: Liou, Li-Syue, et al.
Publicado: (2014)

Acrylamide Induces Mitophagy and Alters Macrophage Phenotype via Reactive Oxygen Species Generation
por: Hung, Chih-Hsing, et al.
Publicado: (2021)

ODP153 Recurrent hypertriglyceridemia-induced pancreatitis due to multifactorial chylomicronemia syndrome in a patient with ketosis-prone diabetes mellitus
por: Thewjitcharoen, Yotsapon, et al.
Publicado: (2022)

Novel Pharmacological Therapies for the Management of Hyperlipoproteinemia(a)
por: Kosmas, Constantine E., et al.
Publicado: (2023)

Uncommon liver tumors: Case report and literature review
por: Wu, Chia-Hung, et al.
Publicado: (2016)

Eruptive Xanthomas Caused by Primary Type V Hyperlipoproteinemia
por: Nakamura, Yoshihiro, et al.
Publicado: (2021)

Hyperlipoproteinemia(a) and Severe Coronary Artery Lesion Types
por: Ilina, Larisa N., et al.
Publicado: (2022)

Associations between Hypertriglyceridemia and Circulating Neutrophil Subpopulation in Patients with Dyslipidemia
por: Genkel, Vadim, et al.
Publicado: (2021)

Loss-of-Function Homozygous Variant in LPL Causes Type I Hyperlipoproteinemia and Renal Lipidosis
por: Wu, Hongyan, et al.
Publicado: (2023)

A Comprehensive Update on the Chylomicronemia Syndrome
por: Goldberg, Ronald B., et al.
Publicado: (2020)

Current Diagnosis and Management of Primary Chylomicronemia
por: Okazaki, Hiroaki, et al.
Publicado: (2021)

The Evolving Story of Multifactorial Chylomicronemia Syndrome
por: Paquette, Martine, et al.
Publicado: (2022)

Rare Treatments for Rare Dyslipidemias: New Perspectives in the Treatment of Homozygous Familial Hypercholesterolemia (HoFH) and Familial Chylomicronemia Syndrome (FCS)
por: D’Erasmo, Laura, et al.
Publicado: (2021)

Primary and secondary prevention of cardiovascular disease in patients with hyperlipoproteinemia (a)
por: Grützmacher, P., et al.
Publicado: (2017)

A rare case of COVID-19 pneumonia with severe hyperlipoproteinemia
por: Shimoda, Masafumi, et al.
Publicado: (2022)

A Case of Type V Hyperlipoproteinemia Resistant to Insulin Treatment
por: Mangeshkar, Shaunak, et al.
Publicado: (2023)

Instillation of particulate matter 2.5 induced acute lung injury and attenuated the injury recovery in ACE2 knockout mice
por: Lin, Chung-I, et al.
Publicado: (2018)

Development of a novel PRO instrument for use in familial chylomicronemia syndrome
por: Davidson, David, et al.
Publicado: (2021)

Clinical and Radiographic Outcomes of Inversed Restricted Kinematic Alignment Total Knee Arthroplasty by Asia Specific (Huang’s) Phenotypes, a Prospective Pilot Study
por: Hsieh, Shang-Lin, et al.
Publicado: (2023)

Deletion of GPIHBP1 causing severe chylomicronemia
por: Rios, Jonathan J., et al.
Publicado: (2011)

Two Case Reports of Familial Chylomicronemia Syndrome
por: Chen, Yan-Hui, et al.
Publicado: (2012)

The burden of familial chylomicronemia syndrome in Canadian patients
por: Gaudet, Daniel, et al.
Publicado: (2020)

Familial chylomicronemia syndrome: a case report
por: Susheela, Ammu Thampi, et al.
Publicado: (2021)

Non-Alcoholic Fatty Liver in Patients with Chylomicronemia
por: Maltais, Mélanie, et al.
Publicado: (2021)

Familial chylomicronemia syndrome: importance of diagnostic vigilance
por: Ueda, Masako
Publicado: (2022)

The Effects of Biologics on Hematologic Malignancy Development in Patients with Ankylosing Spondylitis, Psoriasis, or Psoriatic Arthritis: A National Cohort Study
por: Tsai, Chia-Jung, et al.
Publicado: (2023)

Heterogeneous nanoscopic lipid diffusion in the live cell membrane and its dependency on cholesterol
por: Chai, Yu-Jo, et al.
Publicado: (2022)

SUN-056 Recurrent Pancreatitis Induced by Uncontrolled Type V Hyperlipoproteinemia
por: Rivera Rivero, Bianshly, et al.
Publicado: (2019)

Modern prevalence of dysbetalipoproteinemia (Fredrickson-Levy-Lees type III hyperlipoproteinemia)
por: Pallazola, Vincent A., et al.
Publicado: (2019)

Hyperlipoproteinemia (a) is associated with breast cancer in a Han Chinese population
por: Xu, Jing, et al.
Publicado: (2020)

Association of Dyslipidemia with Renal Outcomes in Chronic Kidney Disease
por: Chen, Szu-Chia, et al.
Publicado: (2013)

Relationship between Dry Eye Disease and Dyslipidemia: A Systematic Review
por: Wang, Tzu-Hao, et al.
Publicado: (2023)

Better Progression-Free Survival in Elderly Patients with Stage IV Lung Adenocarcinoma Harboring Uncommon Epidermal Growth Factor Receptor Mutations Treated with the First-line Tyrosine Kinase Inhibitors
por: Tsai, Ming-Ju, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_13mkmu8sbud9ht64j3r8g15kcu